Honz Pharmaceutical Co., Ltd. (300086.SZ)
CNY 4.36
(3.32%)
CNY 4.36
(3.32%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 416.31 Million CNY | -4.13% |
| 2022 | 393.53 Million CNY | -3.28% |
| 2021 | 406.88 Million CNY | 4.85% |
| 2020 | 388.04 Million CNY | -17.05% |
| 2019 | 467.83 Million CNY | 34.4% |
| 2018 | 348.09 Million CNY | 122.01% |
| 2017 | 156.79 Million CNY | -2.04% |
| 2016 | 160.05 Million CNY | 6.93% |
| 2015 | 149.68 Million CNY | -9.63% |
| 2014 | 165.63 Million CNY | 15.59% |
| 2013 | 143.29 Million CNY | -19.97% |
| 2012 | 179.04 Million CNY | 17.67% |
| 2011 | 152.15 Million CNY | 110.77% |
| 2010 | 72.19 Million CNY | 62.63% |
| 2009 | 44.39 Million CNY | 50.17% |
| 2008 | 29.56 Million CNY | 42.82% |
| 2007 | 20.69 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 125.71 Million CNY | 27.64% |
| 2024 Q1 | 98.49 Million CNY | -14.97% |
| 2024 Q3 | 100.34 Million CNY | -25.44% |
| 2023 Q2 | 88.28 Million CNY | 27.85% |
| 2023 Q1 | 69.05 Million CNY | -46.65% |
| 2023 Q4 | 115.83 Million CNY | 11.25% |
| 2023 Q3 | 104.12 Million CNY | 17.94% |
| 2023 FY | 377.3 Million CNY | -4.13% |
| 2022 Q1 | 90.74 Million CNY | 30.05% |
| 2022 FY | 393.53 Million CNY | -3.28% |
| 2022 Q4 | 129.45 Million CNY | 54.96% |
| 2022 Q3 | 83.53 Million CNY | -6.97% |
| 2022 Q2 | 89.79 Million CNY | -1.05% |
| 2021 Q4 | 69.77 Million CNY | -42.75% |
| 2021 Q3 | 121.88 Million CNY | 1.53% |
| 2021 Q1 | 95.17 Million CNY | -14.43% |
| 2021 Q2 | 120.04 Million CNY | 26.13% |
| 2021 FY | 406.88 Million CNY | 4.85% |
| 2020 FY | 388.04 Million CNY | -17.05% |
| 2020 Q2 | 92.43 Million CNY | 16.3% |
| 2020 Q3 | 104.9 Million CNY | 13.5% |
| 2020 Q4 | 111.22 Million CNY | 6.02% |
| 2020 Q1 | 79.47 Million CNY | -41.86% |
| 2019 Q2 | 138.37 Million CNY | 63.28% |
| 2019 FY | 467.83 Million CNY | 34.4% |
| 2019 Q1 | 84.74 Million CNY | -24.77% |
| 2019 Q4 | 136.71 Million CNY | 26.59% |
| 2019 Q3 | 107.99 Million CNY | -21.95% |
| 2018 Q1 | 40.51 Million CNY | -12.69% |
| 2018 Q3 | 143.13 Million CNY | 176.38% |
| 2018 FY | 348.09 Million CNY | 122.01% |
| 2018 Q4 | 112.65 Million CNY | -21.3% |
| 2018 Q2 | 51.78 Million CNY | 27.82% |
| 2017 Q4 | 46.4 Million CNY | 28.83% |
| 2017 FY | 156.79 Million CNY | -2.04% |
| 2017 Q1 | 33.09 Million CNY | -38.4% |
| 2017 Q2 | 41.27 Million CNY | 24.74% |
| 2017 Q3 | 36.01 Million CNY | -12.75% |
| 2016 Q3 | 33.66 Million CNY | -18.24% |
| 2016 Q4 | 53.72 Million CNY | 59.58% |
| 2016 Q1 | 31.49 Million CNY | -10.7% |
| 2016 FY | 160.05 Million CNY | 6.93% |
| 2016 Q2 | 41.17 Million CNY | 30.74% |
| 2015 Q2 | 31.83 Million CNY | -13.43% |
| 2015 Q4 | 35.26 Million CNY | -22.99% |
| 2015 Q3 | 45.79 Million CNY | 43.86% |
| 2015 FY | 149.68 Million CNY | -9.63% |
| 2015 Q1 | 36.77 Million CNY | -25.02% |
| 2014 Q4 | 49.04 Million CNY | 6.17% |
| 2014 Q3 | 46.19 Million CNY | 35.09% |
| 2014 Q2 | 34.19 Million CNY | -5.5% |
| 2014 Q1 | 36.18 Million CNY | -13.76% |
| 2014 FY | 165.63 Million CNY | 15.59% |
| 2013 Q2 | 31.71 Million CNY | -5.26% |
| 2013 FY | 143.29 Million CNY | -19.97% |
| 2013 Q4 | 41.96 Million CNY | 16.12% |
| 2013 Q3 | 36.13 Million CNY | 13.93% |
| 2013 Q1 | 33.48 Million CNY | -36.11% |
| 2012 Q4 | 52.4 Million CNY | 23.59% |
| 2012 Q2 | 48.88 Million CNY | 38.31% |
| 2012 Q3 | 42.4 Million CNY | -13.26% |
| 2012 Q1 | 35.34 Million CNY | -32.3% |
| 2012 FY | 179.04 Million CNY | 17.67% |
| 2011 Q3 | 42.21 Million CNY | 19.24% |
| 2011 Q4 | 52.2 Million CNY | 23.68% |
| 2011 FY | 152.15 Million CNY | 110.77% |
| 2011 Q1 | 22.33 Million CNY | -30.46% |
| 2011 Q2 | 35.4 Million CNY | 58.48% |
| 2010 Q3 | 16.89 Million CNY | 34.79% |
| 2010 Q2 | 12.53 Million CNY | 17.92% |
| 2010 FY | 72.19 Million CNY | 62.63% |
| 2010 Q1 | 10.63 Million CNY | -38.47% |
| 2010 Q4 | 32.12 Million CNY | 90.08% |
| 2009 Q2 | 12.05 Million CNY | 178.69% |
| 2009 FY | 44.39 Million CNY | 50.17% |
| 2009 Q1 | 4.32 Million CNY | 0.0% |
| 2009 Q4 | 17.28 Million CNY | 60.99% |
| 2009 Q3 | 10.73 Million CNY | -10.95% |
| 2008 FY | 29.56 Million CNY | 42.82% |
| 2007 FY | 20.69 Million CNY | 0.0% |